Milestone Pharmaceuticals (MIST)

• Market cap: $147M
• 1 day: 1.17%
• 5 days: 1.76%
• 1 month: -11.73%
• 3 months: -34.72%
• 6 months: -5.98%
• Year to date: -15.61%
• 1 year: 4.85%
• 5 years: -75.14%
• 10 years: -88.74%
• Sector: Healthcare
• Industry: Biotechnology

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Employees: 33